miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1. (Q39135735)

9 September 2017

title

miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1. (English)

1 reference

9 September 2017

1 reference

Yiwei Lin

1

1 reference

9 September 2017

Hong Chen

2

1 reference

9 September 2017

Zhenghui Hu

3

1 reference

9 September 2017

Yeqing Mao

4

1 reference

9 September 2017

Xianglai Xu

5

1 reference

9 September 2017

Yi Zhu

6

1 reference

9 September 2017

Xin Xu

7

1 reference

9 September 2017

Jian Wu

8

1 reference

9 September 2017

Shiqi Li

9

1 reference

9 September 2017

Qiqi Mao

10

1 reference

9 September 2017

Xiangyi Zheng

11

1 reference

9 September 2017

Liping Xie

12

1 reference

9 September 2017

language of work or name

English

0 references

publication date

22 June 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

587

1 reference

9 September 2017

issue

15

1 reference

9 September 2017

page(s)

2467-2473

1 reference

Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumors at diagnosis

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

Bladder cancer risk from occupational and environmental exposures

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

MicroRNA in prostate, bladder, and kidney cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

microRNAs: tiny regulators with great potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

Up-regulation of microRNA in bladder tumor tissue is not common.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

HMGA1 controls transcription of insulin receptor to regulate cyclin D1 translation in pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

Small molecules with big effects: the role of the microRNAome in cancer and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

Dysregulation of microRNAs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

Roles of HMGA proteins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.021

10.1016/J.FEBSLET.2013.06.021

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference